Cot inhibitor-1,
915365-57-0,
8-chloro-4-[(3-chloro-4-fluorophenyl)amino]-6-[[[1-[2-(hexahydro-1H-azepin-1-yl)ethyl]-1H-1,2,3-triazol-4-yl]methyl]amino]-3-Quinolinecarbonitrile,
3-Quinolinecarbonitrile, 8-chloro-4-[(3-chloro-4-fluorophenyl)amino]-6-[[[1-[2-(hexahydro-1H-azepin-1-yl)ethyl]-1H-1,2,3-triazol-4-yl]methyl]amino]-,
C27H27Cl2FN8,
CHEMBL496594,
BDBM29917,
DTXSID70468951,
3365AH,
ZINC43132692,
AKOS030526991,
NCGC00378798-01,
6-[[[1-[2-(AZEPAN-1-YL)ETHYL]-1H-1,2,3-TRIAZOL-4-YL]METHYL]AMINO]-8-CHLORO-4-[(3-CHLORO-4-FLUOROPHENYL)AMINO]QUINOLINE-3-CARBONITRILE,
AN-26363,
HY-32015,
DB-015003,
FT-0718386,
W-5555,
substituted 6-aminoquinoline-3-carbonitrile, 28,
365Q570,
6-[[1-[2-(azepan-1-yl)ethyl]triazol-4-yl]methylamino]-8-chloro-4-(3-chloro-4-fluoro-anilino)quinoline-3-carbonitrile,
CS-0032,
CID11584834,
CID 11584834,
A3328,